|
|||||
|
|
Phase I trial of afatinib plus vinorelbine in Japanese patients with advanced solid tumors,including breast cancer |
|
| Authors: | Hirofumi Mukai Norikazu Masuda Hiroshi Ishiguro Ayako Mitsuma Takashi Shibata Jun Yamamura Masakazu Toi Aiko Watabe Akiko Sarashina Martina Uttenreuther-Fischer Yuichi Ando |
| Affiliation: | 1. Division of Oncology/Hematology, National Cancer Center Hospital East, Kashiwa, Japan 2. Department of Surgery, Breast Oncology, Osaka National Hospital, Osaka, Japan 3. Outpatient Oncology Unit, Kyoto University Hospital, Kyoto, Japan 4. Department of Clinical Oncology and Chemotherapy, Nagoya University Hospital, Nagoya, Japan 5. Department of Mammary Gland and Internal Secretion Surgery, Sakai City Hospital, Sakai, Japan 6. Department of Breast Surgery, Kyoto University Hospital, Kyoto, Japan 7. Clinical Trial Management Department, Nippon Boehringer Ingelheim Co. Ltd., Tokyo, Japan 8. Clinical PK/PD Department, Nippon Boehringer Ingelheim Co. Ltd., Kobe, Hyogo, Japan 9. TA Oncology, Boehringer Ingelheim Pharma GmbH and Co. KG, Biberach, Germany |
| Abstract: | |
| Keywords: | |
| 本文献已被 SpringerLink 等数据库收录！ | |